终末红系分化严重受损作为骨髓增生异常综合征的独立预后标志物
研究对221份骨髓样本(MDS 205份来自113例患者,正常16份)检测终末红系分化(TED)阶段特异性异常,发现27%的MDS样本无可量化TED,且与总生存期显著更差(56 vs 103个月,P=.0001)及SRSF2突变相关;多变量分析显示无TED是跨IPSS-R分级的独立预后不良标志。
要点
- 27%的MDS样本无可量化终末红系分化,与总生存期显著更差相关(56 vs 103个月,P=.0001)。
- 无TED是跨IPSS-R分级、髓红比例及多基因突变校正后的独立预后不良标志。
- SRSF2突变与无TED更频繁相关(7/23,P<.05)。
核心结论
- 无TED是MDS中跨所有IPSS-R分级的强独立预后不良标志,且SRSF2突变与无TED更频繁相关。
研究设计与样本
- 研究纳入221份新鲜骨髓样本,其中MDS 205份来自113例不同患者,正常16份,通过检测血型糖蛋白A、条带3和整合素α-4的表面表达来评估终末红系分化阶段特异性异常。
主要发现
- 在27%的MDS样本(56/205)中,终末分化红系母细胞通过整合素α-4和条带3表面表达未显示可量化的TED。
- 无可量化TED与总生存期显著更差相关(56 vs 103个月,P=.0001),并与SRSF2突变相关(7/23,P<.05)。
- 多变量Cox比例风险回归分析显示,无TED在跨IPSS-R分级、髓红比例及多个基因突变中仍保持独立显著性。
- 在149/205份MDS样本中,经历TED的细胞比例未遵循连续阶段预期的1:2:4:8:16倍增模式。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Anemia is the defining feature in most patients with myelodysplastic syndromes (MDS), yet defects in erythropoiesis have not been well characterized. We examined freshly obtained bone marrow (BM) samples for stage-specific abnormalities during terminal erythroid differentiation (TED) from 221 samples (MDS, n = 205 from 113 unique patients; normal, n = 16) by measuring the surface expression of glycophorin A, band 3, and integrin α-4. Clinical and biologic associations were sought with presence or absence of TED and the specific stage of erythroid arrest. In 27% of MDS samples (56/205), there was no quantifiable TED documented by surface expression of integrin α-4 and band 3 by terminally differentiating erythroblasts. Absence of quantifiable TED was associated with a significantly worse overall survival (56 vs 103 months, P = .0001) and SRSF2 mutations (7/23, P < .05). In a multivariable Cox proportional hazards regression analysis, absence of TED remained independently significant across International Prognostic Scoring System-Revised (IPSS-R) categories, myeloid/erythroid ratio, and mutations in several genes. In 149/205 MDS samples, the proportion of cells undergoing TED did not follow the expected 1:2:4:8:16 doubling pattern in successive stages. Absence of TED emerged as a powerful independent prognostic marker of poor overall survival across all IPSS-R categories in MDS, and SRSF2 mutations were more frequently associated with absence of TED.
引用
- Ali AM, Huang Y, Pinheiro RF, et al. Severely impaired terminal erythroid differentiation as an independent prognostic marker in myelodysplastic syndromes. Blood Adv. 2018. PMID: 29903708. doi:10.1182/bloodadvances.2018018440
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。